BioLineRx Ltd. (NASDAQ: BLRX) disclosed today positive Phase 2a correlative data, as well as detailed mechanism-of-action data, for BL-8040, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE